Glomerular Disease in Liver Disease

Sharma, Purva; Airy, Medha

doi:10.1016/j.cld.2022.01.007

Cited by 8 publications

(10 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Normally, the liver performs several vital functions in the body, including detoxification, metabolism, nutrient storage, bile production, and the synthesis of proteins necessary for blood clotting and immune function. A patient with Chronic Liver Disease (CLD), however, may experience difficulties in performing those liver functions [9]. While there are various causes of liver damage, CLD patients usually experience the same course of progression.…”

Section: Adapting the Dash Diet For Individuals With Chronic Liver Di...mentioning

confidence: 99%

“…In addition to recommending appropriate water intake, the DASH diet also emphasizes the importance of limited sodium intake while increasing potassium intake to drop blood pressure [3]. This recommendation aligns with the dietary guidelines for individuals with advanced Chronic Liver Disease (CLD) who are advised to lower their sodium intake [9]. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), patients with cirrhosis should limit their daily sodium intake to 2300 mg [14], which is consistent with the sodium intake recommended in the DASH diet [2].…”

Section: Adapting the Dash Diet For Individuals With Chronic Liver Di...mentioning

confidence: 99%

See 1 more Smart Citation

Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease

Zhu

2023

TNS

View full text Add to dashboard Cite

Hypertension is a significant risk factor for cardiovascular diseases, and the DASH diet effectively lowers blood pressure. However, individuals with Chronic Kidney Disease (CKD) and Chronic Liver Disease (CLD) need adaptations in potassium and sodium/water intake to adhere to the DASH diet. This literature review examines the applicability of the DASH diet for patients with CKD and CLD by analyzing findings from a comprehensive search of relevant academic databases. The review explores various sources, including clinical studies, research articles, and expert recommendations, to assess the effectiveness and suitability of the DASH diet in managing the dietary needs of individuals with CKD and CLD. The review reveals that the DASH diet, with its emphasis on reduced sodium intake and increased consumption of fruits, vegetables, whole grains, and lean proteins, shows promising results in managing blood pressure and improving overall cardiovascular health in individuals with early stage CKD and CLD. Furthermore, the review concludes that individuals with advanced CKD and CLD should exercise caution when considering the DASH diet, as modifications are necessary to accommodate their specific conditions. For patients with advanced CKD, careful management of potassium intake is essential to prevent hyperkalemia; while individuals with late-stage CLD should monitor both sodium and water intake to avoid dilutional hyponatremia. Additionally, the review also emphasized the importance of individualized dietary modifications and consultations with healthcare professionals for optimizing the benefits of the DASH diet, especially for those patients with later stages of CKD and CLD.

show abstract

Section: Adapting the Dash Diet For Individuals With Chronic Liver Di...mentioning

confidence: 99%

Section: Adapting the Dash Diet For Individuals With Chronic Liver Di...mentioning

confidence: 99%

Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease

Zhu

2023

TNS

View full text Add to dashboard Cite

show abstract

“…According to the CDC, 4.5 million or 1.8% of the adult population in the US has been diagnosed with CLD, and 51,642 deaths yearly are attributable to CLD or cirrhosis complications. [7] Among patients awaiting transplant without HCC, NAFLD and alcoholic liver disease are the most common etiologies. [8] Globally, barriers to care include physical, geographical, and socioeconomic limitations to accessing screening and treatment.…”

Section: Introductionmentioning

confidence: 99%

“…Chronic liver disease (CLD) is a leading cause of morbidity and mortality in the US and can be due to various etiologies such as alcohol-associated liver disease, viral hepatitis such as HCV, autoimmune hepatitis (AIH), and NAFLD. According to the CDC, 4.5 million or 1.8% of the adult population in the US has been diagnosed with CLD, and 51,642 deaths yearly are attributable to CLD or cirrhosis complications 7 . Among patients awaiting transplant without HCC, NAFLD and alcoholic liver disease are the most common etiologies 8 .…”

Section: Introductionmentioning

confidence: 99%

Telehealth interventions in patients with chronic liver diseases: A systematic review

et al. 2023

View full text Add to dashboard Cite

Background and Aim: Telehealth interventions may improve access to care, disease-specific, and quality outcomes in chronic liver diseases (CLDs). We aimed to systematically evaluate outcomes of telehealth interventions in CLDs. Materials and Methods: We used key terms and searched PubMed/ EMBASE from inception to January 10, 2022. Two authors independently screened abstracts. Disagreements were resolved by a third reviewer. We included any type of CLD, including posttransplant patients, and extracted outcomes as defined by authors for each etiology of CLD (sustained virological response in HCV or weight loss in NAFLD). Meta-analysis was not performed because of the heterogeneity of data. Quality assessment was performed using the Newcastle-Ottawa Scale for observational studies and the Cochrane Risk of Bias tool for clinical trials.Results: Of 4250 studies screened, 43 met the inclusion criteria. Of these, 28 reported HCV treatment outcomes. All studies showed no statistically significant differences between sustained virological response rates in TH groups compared with control groups or historic cohorts. Eight studies evaluating liver transplant-related processes and outcomes demonstrated improved rates of transplant evaluation and referrals and decreased shortterm readmission rates. Three randomized controlled trials and 1 observational study on NAFLD showed improved weight loss outcomes. One retrospective study showed reduced mortality risk in CLD patients with at least 1 TH encounter.

show abstract

“…triển kéo dài trên 6 tháng 2 . Trong đó rượu là một trong những nguyên nhân phổ biến nhất gây ra bệnh gan mạn tính trên thế giới.…”

unclassified

Khảo Sát Giá Trị Thang Điểm Abic (Age Bilirubin Inr Creatinine) Trong Tiên Lượng Bệnh Gan Mạn Do Rượu

Ngô,

Dương,

Trần

et al. 2024

VMJ

View full text Add to dashboard Cite

Mở đầu: Bệnh gan do rượu bao gồm nhiều rối loạn lâm sàng: gan nhiễm mỡ do rượu, viêm gan do rượu (Alcoholic hepatitis - AH) các mức độ, xơ gan rượu (Alcoholic cirrhosis - AC) đi kèm các biến chứng của nó và viêm gan rượu cấp tính biểu hiện như đợt cấp suy gan mạn, gây nên bởi việc sử dụng rượu kéo dài1. Có rất nhiều các chỉ số để đánh giá tiên lượng bệnh nhân bệnh gan do rượu, trong đó thang điểm ABIC được sử dụng ngày càng rộng rãi. Mục tiêu: Khảo sát giá trị thang điểm ABIC trong tiên lượng bệnh gan mạn do rượu. Đối tượng và phương pháp nghiên cứu: Nghiên cứu hồi cứu và tiến cứu. 62 bệnh nhân được chẩn đoán bệnh gan mạn do rượu theo hướng dẫn chẩn đoán của Hội Tiêu hóa Hoa Kỳ (ACG) 2018 điều trị tại khoa Nội tổng hợp Bệnh viện Đại học Y Hà Nội từ tháng 1/2022 đến tháng 1/2023. Kết quả và kết luận: Có 62 bệnh nhân thỏa mãn tiêu chuẩn. Tuổi trung bình của các đối tượng là 53.9 ± 9.4. Điểm ABIC trung bình là 7.28 ± 1.17, cao nhất là 10.06, thấp nhất là 4.42. Có mối liên quan giữa thang điểm ABIC và tiên lượng tử vong sau 30 ngày của bệnh gan mạn do rượu với giá trị cut-off 8.26, AUROC 0.884, p = 0.002 < 0.05, độ nhạy Se (Sensitivity) là 83.3% và độ đặc hiệu Sp (Specificity) là 89.3%.

show abstract

Glomerular Disease in Liver Disease

Cited by 8 publications

References 52 publications

Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease

Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease

Telehealth interventions in patients with chronic liver diseases: A systematic review

Khảo Sát Giá Trị Thang Điểm Abic (Age Bilirubin Inr Creatinine) Trong Tiên Lượng Bệnh Gan Mạn Do Rượu

Contact Info

Product

Resources

About